201 related articles for article (PubMed ID: 20302626)
1. ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.
Kwon S; Kim D; Rhee JW; Park JA; Kim DW; Kim DS; Lee Y; Kwon HJ
BMC Biol; 2010 Mar; 8():23. PubMed ID: 20302626
[TBL] [Abstract][Full Text] [Related]
2. How the ankyrin and SOCS box protein, ASB9, binds to creatine kinase.
Balasubramaniam D; Schiffer J; Parnell J; Mir SP; Amaro RE; Komives EA
Biochemistry; 2015 Mar; 54(8):1673-80. PubMed ID: 25654263
[TBL] [Abstract][Full Text] [Related]
3. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.
Uranbileg B; Enooku K; Soroida Y; Ohkawa R; Kudo Y; Nakagawa H; Tateishi R; Yoshida H; Shinzawa S; Moriya K; Ohtomo N; Nishikawa T; Inoue Y; Tomiya T; Kojima S; Matsuura T; Koike K; Yatomi Y; Ikeda H
Int J Cancer; 2014 May; 134(9):2189-98. PubMed ID: 24174293
[TBL] [Abstract][Full Text] [Related]
4. Ankyrin-repeat and SOCS box-containing protein 9 (ASB9) regulates ovarian granulosa cells function and MAPK signaling.
Nosratpour S; Ndiaye K
Mol Reprod Dev; 2021 Dec; 88(12):830-843. PubMed ID: 34476862
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin regulation of ankyrin-repeat and SOCS-box protein 9 (ASB9) in ovarian follicles and identification of binding partners.
Benoit G; Warma A; Lussier JG; Ndiaye K
PLoS One; 2019; 14(2):e0212571. PubMed ID: 30811458
[TBL] [Abstract][Full Text] [Related]
6. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases.
Muniz JR; Guo K; Kershaw NJ; Ayinampudi V; von Delft F; Babon JJ; Bullock AN
J Mol Biol; 2013 Sep; 425(17):3166-77. PubMed ID: 23806657
[TBL] [Abstract][Full Text] [Related]
7. Model of the Ankyrin and SOCS Box Protein, ASB9, E3 Ligase Reveals a Mechanism for Dynamic Ubiquitin Transfer.
Schiffer JM; Malmstrom RD; Parnell J; Ramirez-Sarmiento C; Reyes J; Amaro RE; Komives EA
Structure; 2016 Aug; 24(8):1248-1256. PubMed ID: 27396830
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of Human ASB9-2 and substrate-recognition of CKB.
Fei X; Gu X; Fan S; Yang Z; Li F; Zhang C; Gong W; Mao Y; Ji C
Protein J; 2012 Apr; 31(4):275-84. PubMed ID: 22418839
[TBL] [Abstract][Full Text] [Related]
9. Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases.
Thomas JC; Matak-Vinkovic D; Van Molle I; Ciulli A
Biochemistry; 2013 Aug; 52(31):5236-46. PubMed ID: 23837592
[TBL] [Abstract][Full Text] [Related]
10. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
Linossi EM; Nicholson SE
IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin protein E3 ligase ASB9 suppresses proliferation and promotes apoptosis in human spermatogonial stem cell line by inducing HIF1AN degradation.
Li N; Zhou Q; Yi Z; Zhang H; Zhou D
Biol Res; 2023 Jan; 56(1):4. PubMed ID: 36683111
[TBL] [Abstract][Full Text] [Related]
12. Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity.
Li JY; Chai BX; Zhang W; Liu YQ; Ammori JB; Mulholland MW
Cell Signal; 2007 Jun; 19(6):1185-92. PubMed ID: 17276034
[TBL] [Abstract][Full Text] [Related]
13. Signaling Size: Ankyrin and SOCS Box-Containing ASB E3 Ligases in Action.
Liu P; Verhaar AP; Peppelenbosch MP
Trends Biochem Sci; 2019 Jan; 44(1):64-74. PubMed ID: 30446376
[TBL] [Abstract][Full Text] [Related]
14. Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation.
Debrincat MA; Zhang JG; Willson TA; Silke J; Connolly LM; Simpson RJ; Alexander WS; Nicola NA; Kile BT; Hilton DJ
J Biol Chem; 2007 Feb; 282(7):4728-4737. PubMed ID: 17148442
[TBL] [Abstract][Full Text] [Related]
15. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes.
Kohroki J; Nishiyama T; Nakamura T; Masuho Y
FEBS Lett; 2005 Dec; 579(30):6796-802. PubMed ID: 16325183
[TBL] [Abstract][Full Text] [Related]
16. Structure and dynamics of the ASB9 CUL-RING E3 Ligase.
Lumpkin RJ; Baker RW; Leschziner AE; Komives EA
Nat Commun; 2020 Jun; 11(1):2866. PubMed ID: 32513959
[TBL] [Abstract][Full Text] [Related]
17. ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism.
Ferguson JE; Wu Y; Smith K; Charles P; Powers K; Wang H; Patterson C
Mol Cell Biol; 2007 Sep; 27(18):6407-19. PubMed ID: 17636018
[TBL] [Abstract][Full Text] [Related]
18. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.
Chung AS; Guan YJ; Yuan ZL; Albina JE; Chin YE
Mol Cell Biol; 2005 Jun; 25(11):4716-26. PubMed ID: 15899873
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of ASB9 in human colorectal cancer.
Tokuoka M; Miyoshi N; Hitora T; Mimori K; Tanaka F; Shibata K; Ishii H; Sekimoto M; Doki Y; Mori M
Int J Oncol; 2010 Nov; 37(5):1105-11. PubMed ID: 20878058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
